Allogeneic stem cell transplantation from unrelated donors after dose-reduced intensity conditioning regimen for patients with multiple myeloma and relapse after autologous stem cell transplantation: A phase II-study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Immunosuppressants
- Indications Graft-versus-host disease; Multiple myeloma
- Focus Therapeutic Use
- 02 Dec 2015 Biomarkers information updated
- 28 Oct 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Oct 2008 Actual patient number (50) added as reported by ClinicalTrials.gov.